Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | MGLL | Q99685 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL34472404 | 0.91 | USP2 (0.44) | USP2KDM4ESMN1; SMN2ALDH1A1KEAP1 | |
| SCHEMBL10447084 | 0.91 | HRH3 (0.47) | USP2KDM4ESMN1; SMN2ALDH1A1KEAP1 | |
| SCHEMBL949341 | 0.88 | HRH3 (0.50) | USP2KDM4ESMN1; SMN2ALDH1A1KEAP1 | |
| SCHEMBL13923300 | 0.84 | KDM4E (0.48) | USP2KDM4ESMN1; SMN2ALDH1A1KEAP1 | |
| SCHEMBL28315050 | 0.84 | USP2 (0.39) | USP2KDM4ESMN1; SMN2ALDH1A1KEAP1 | |
| SCHEMBL949546 | 0.84 | USP2 (0.39) | USP2KDM4ESMN1; SMN2ALDH1A1KEAP1 | |
| SCHEMBL27297868 | 0.84 | USP2 (0.39) | USP2KDM4ESMN1; SMN2ALDH1A1KEAP1 | |
| SCHEMBL235080 | 0.81 | KDM4E (0.65) | USP2KDM4ESMN1; SMN2ALDH1A1KEAP1 | |
| SCHEMBL3380412 | 0.80 | USP2 (0.40) | USP2KDM4ESMN1; SMN2ALDH1A1KEAP1 | |
| SCHEMBL23273615 | 0.80 | KEAP1 (0.40) | USP2KDM4ESMN1; SMN2ALDH1A1KEAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 545 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260078296-A1 | SUSTAINED-RELEASE SCALE INHIBITORS | Materials Engineering and Technical Support Services (US) | 2026-03-19 | — | — | US | claimed |
| EP-3999618-B1 | METAL WORKING FLUID | ITALMATCH SC LLC (US) | 2025-03-12 | — | — | EP | claimed |
| EP-4516862-A1 | AQUEOUS COATING COMPOSITION, COATING OBTAINED FROM THE COATING COMPOSITION, SUBSTRATE CONTAINING THE COATING AND THE USE OF THE AQUEOUS COATING COMPOSITION | DAW SE (DE) | 2025-03-05 | — | — | EP | claimed |
| CN-115928073-B | Grinding fluid and preparation method and application thereof | 广东红日星实业有限公司 | 2025-01-07 | — | — | CN | claimed |
| CN-119120846-A | Metal heat treatment process | 扬州恒众精密机械有限公司 | 2024-12-13 | — | — | CN | claimed |
| CN-118853275-A | Fully-synthetic cutting grinding fluid with hard water resistance and emulsification resistance | 欣格瑞（山东）环境科技有限公司 | 2024-10-29 | — | — | CN | claimed |
| CN-118667602-A | High-cleaning copper wire drawing liquid and preparation method thereof | 超滑科技(佛山)有限责任公司 | 2024-09-20 | — | — | CN | claimed |
| WO-2024059615-A2 | SUSTAINED-RELEASE SCALE INHIBITORS | MATERIALS ENGINEERING AND TECHNICAL SUPPORT SERVICES CORPORATION (US) | 2024-03-21 | — | — | WO | claimed |
| CN-117660093-A | Water-based aluminum alloy drawing liquid and preparation method thereof | 超滑科技(佛山)有限责任公司 | 2024-03-08 | — | — | CN | claimed |
| CN-112679431-B | Method for preparing isoquinolinones compound | 上海迪赛诺化学制药有限公司 | 2023-05-05 | — | — | CN | claimed |
| US-7521565-B2 | Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazole-1-yl)methyl]-4H-carbazol-4-one or its salt | YUHAN CORPORATION (KR) | 2009-04-21 | — | — | US | claimed |
| WO-2009047175-A2 | RODENTICIDE MIXTURE | BASF SE (DE) | 2009-04-16 | — | — | WO | claimed |
| WO-2009043773-A1 | BIOCIDAL MIXTURES | LANXESS DEUTSCHLAND GMBH (DE) | 2009-04-09 | — | — | WO | claimed |
| EP-2042489-A1 | Removal and prevention of discolouration of pyrithione-containing materials | Straetmans high TAC GmbH (DE) | 2009-04-01 | — | — | EP | claimed |
| WO-2008088632-A2 | AMINOALCOHOL AND BIOCIDE COMPOSITIONS FOR AQUEOUS BASED SYSTEMS | ANGUS CHEMICAL COMPANY (US) | 2008-07-24 | — | — | WO | claimed |
| US-20070292465-A1 | Eutectic biocide compositions and formulations | CLARIANT INTERNATIONAL, LTD. | 2007-12-20 | — | — | US | claimed |
| US-5734056-A | Process for the preparation of certain 9-substituted camptothecins | SMITHKLINE BEECHAM CORPORATION (US) | 1998-03-31 | — | — | US | claimed |
| US-5387393-A | Using amine-aldehyde reaction product | NALCO CHEMICAL COMPANY (US) | 1995-02-07 | — | — | US | claimed |
| US-5324665-A | On-line method for monitoring chloride levels in a fluid stream | NALCO CHEMICAL COMPANY (US) | 1994-06-28 | — | — | US | claimed |
| US-3935205-A | Dimorpholinomethyl-(4-methyl-3-pentenyl)-cyclohexenenes | GIVAUDAN CORPORATION (US) | 1976-01-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078296-A1 | SUSTAINED-RELEASE SCALE INHIBITORS | CEL, TST, CD44 | USP2 60/4885KDM4E 1336/4885SMN1; SMN2 3186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.